Page last updated: 2024-12-06

torpedo

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Torpedo: A genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID33497
SCHEMBL ID10344444
MeSH IDM0021708

Synonyms (19)

Synonym
torpedo
n,n-bis(2-chloroethyl)-4-methyl-2,6-dinitroaniline
chlornidine
26389-78-6
unii-734esh36s2
benzenamine, n,n-bis(2-chloroethyl)-4-methyl-2,6-dinitro-
n,n-bis(2-chloroethyl)-2,6-dinitro-p-toluidine
734esh36s2 ,
caswell no. 089a
ai3-62692
SCHEMBL10344444
XKUWFOYPQIVFMM-UHFFFAOYSA-N
p-toluidine, n,n-bis(2-chloroethyl)-2,6-dinitro-
an 5647
an 56477
n,n-bis(2-chloroethyl)-4-methyl-2,6-dinitroaniline #
DTXSID8042183
n,n-bis(2-chloroethyl)-4-methyl-2,6-dinitrobenzenamine
AKOS040751154

Research Excerpts

Overview

The torpedo ray is a fish with powerful electric organs, which can serve either as predatory tool or defensive weapon. The Torpedo electrocyte is a flattened syncytium derived from skeletal muscle.

ExcerptReferenceRelevance
"Torpedo californica is a species in class Chondrichthyes. "( The proteome survey of an electricity-generating organ (Torpedo californica electric organ).
Hathout, Y; Hoffman, EP; Nazarian, J; Vertes, A, 2007
)
2.03
"The torpedo ray is a fish with powerful electric organs, which can serve either as predatory tool or defensive weapon. "( Atrial fibrillation in a commercial diver.
Hussaini, S; Taimur, Z, 2008
)
0.9
"The Torpedo electrocyte is a flattened syncytium derived from skeletal muscle, characterized by two functionally distinct plasma membrane domains. "( Presence of a protein immunologically related to lamin B in the postsynaptic membrane of Torpedo marmorata electrocyte.
Cartaud, A; Cartaud, J; Courvalin, JC; Ludosky, MA, 1989
)
1.06

Effects

Torpedo NPY has no unique positions when compared with the other sequences. It seems to be identical to the NPY of the common ancestor of cartilaginous fishes, bony fishes, and tetrapods after 420 million years of evolution.

ExcerptReferenceRelevance
"As Torpedo NPY has no unique positions when compared with the other sequences, it seems to be identical to the NPY of the common ancestor of cartilaginous fishes, bony fishes, and tetrapods after 420 million years of evolution."( Strong evolutionary conservation of neuropeptide Y: sequences of chicken, goldfish, and Torpedo marmorata DNA clones.
Blomqvist, AG; Larhammar, D; Lundell, I; Milner, RJ; Söderberg, C, 1992
)
1.02
"The Torpedo enzyme has now been purified to apparent homogeneity from electric organ by a procedure involving affinity chromatography using the selective inhibitor lisinopril immobilised to Sepharose via a 28-A spacer arm."( Purification and characterization of a peptidyl dipeptidase resembling angiotensin converting enzyme from the electric organ of Torpedo marmorata.
Dowdall, MJ; Hooper, NM; Hryszko, J; Turner, AJ, 1987
)
0.96

Toxicity

ExcerptReferenceRelevance
"Crotoxin is the main toxic component of the venom of the South-American rattlesnake Crotalus durissus terrificus."( A monoclonal antibody directed against the non-toxic subunit of a dimeric phospholipase A2 neurotoxin, crotoxin, neutralizes its toxicity.
Bon, C; Choumet, V; Lafaye, P; Mazié, JC, 1998
)
0.3
" Moreover, we propose here that binding of pharmaceuticals to AChE might have a potential in triggering molecular initiating events for adverse outcome pathways (AOPs), which in turn can play an important role for future screening of APIs lacking fish lethality data."( Revisiting fish toxicity of active pharmaceutical ingredients: Mechanistic insights from integrated ligand-/structure-based assessments on acetylcholinesterase.
Eminoğlu, EM; Erdem, SS; Minovski, N; Novič, M; Saçan, MT, 2019
)
0.51

Pharmacokinetics

ExcerptReferenceRelevance
" Differences in the pharmacokinetic parameters of cholinesterases seem to be due to the combined effect of the molecular weight and charge- and size-based heterogeneity in glycans."( Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases.
Ashani, Y; Doctor, BP; Patel, T; Raveh, L; Saxena, A; Stevenson, D, 1998
)
0.3
" Pharmacokinetic modeling revealed no significant differences between myasthenic and control pigs."( Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.
De Baets, MH; De Haes, A; Houwertjes, MC; Proost, JH; Stassen, MH; Wierda, JM, 2003
)
0.32
"This work is aimed to synthesize and evaluate the effect of chalcones on the AChE activity, as well as anti-oxidant activity and predict their pharmacokinetic profile."( Effect on Acetylcholinesterase and Anti-oxidant Activity of Synthetic Chalcones having a Good Predicted Pharmacokinetic Profile.
Almeida, WP; Figueiro, M; Kawano, DF; Sakata, RP, 2017
)
0.46
" Considering the prediction of pharmacokinetic parameters being a useful tool for selecting potential drug candidates, our study results suggest that the majority of chalcones, including the most active one, have a promising pharmacokinetic profile and blood-brain barrier permeability."( Effect on Acetylcholinesterase and Anti-oxidant Activity of Synthetic Chalcones having a Good Predicted Pharmacokinetic Profile.
Almeida, WP; Figueiro, M; Kawano, DF; Sakata, RP, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves of cholinergic compounds and Scatchard plots were generated to evaluate the apparent binding constants."( Microtiter plate binding assay for cholinergic compounds utilizing the nicotinic acetylcholine receptor.
Chen, L; Martin, GB; Rechnitz, GA, 1992
)
0.28
" In 1 out of 4 experiments administration of a nanogram dosage of anti-idiotype antibodies led to an enhanced anti-AChR antibody response after immunization with AChR."( In vivo effects of neonatal administration of antiidiotype antibodies on experimental autoimmune myasthenia gravis.
De Baets, MH; Graus, YM; Tzartos, S; Van Breda Vriesman, PJ; Verschuuren, JJ, 1991
)
0.28
" Specificity was determined by dose-response experiments and competition studies using carbamylcholine chloride, acetylcholine chloride, or Naja naja atra cobrotoxin mixed with receptor."( A non-radioactive receptor assay for snake venom postsynaptic neurotoxins.
Stiles, BG, 1991
)
0.28
" On double-logarithmic coordinates, the dose-response relations all had a slope near 2 for low concentrations of ACh."( Equilibrium properties of mouse-Torpedo acetylcholine receptor hybrids expressed in Xenopus oocytes.
Davidson, N; Lester, HA; Mayne, KM; Yoshii, K; Yu, L, 1987
)
0.56
" ACh dose-response curves suggested that his inhibition was noncompetitive."( Diterpenoids from Caribbean gorgonians act as noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Eterović, VA; Ferchmin, PA; Hann, RM; Lee, YH; Li, L; McNamee, MG; Rodriguez, AD, 1993
)
0.29
" Both types of snake postsynaptic toxins showed a dose-response with constant AchR (50 micrograms/ml) and varying toxin concentrations (50-0."( Acetylcholine receptor binding characteristics of snake and cone snail venom postsynaptic neurotoxins: further studies with a non-radioactive assay.
Stiles, BG, 1993
)
0.29
" Dose-response curves from voltage-clamped oocytes were used to estimate EC50's and Hill coefficients."( Mouse-Torpedo chimeric alpha-subunit used to probe channel-gating determinants on the nicotinic acetylcholine receptor primary sequence.
Butler, DH; Butler, JK; Lasalde, JA; McNamee, MG; Tamamizu, S; Zimmerman, G, 1997
)
0.78
" Dose-response correlations between vesicle density and secretegogue strength (mM) and duration were higher with sucrose."( Dynamic responses of presynaptic terminal membrane pools following KCl and sucrose stimulation.
Fox, GQ; Kriebel, ME, 1997
)
0.3
" Dose-response curve to ACh was not affected by treatment with lysoPA."( Lysophosphatidic acid potentiates ACh receptor currents by G-protein-mediated activation of protein kinase C.
Nishizaki, T; Sumikawa, K, 1997
)
0.3
" Dose-response curves for ouabain, a specific Na(+),K(+)-ATPase inhibitor, were obtained to ascertain which Na(+),K(+)-ATPase isoform(s) is involved."( On the functional interaction between nicotinic acetylcholine receptor and Na+,K+-ATPase.
Drabkina, TM; Eaton, MJ; Kravtsova, VV; Krivoi, II; Mandel, F; Skatchkov, SN; Vasiliev, AN, 2006
)
0.33
" BW284c51 blockade was non-competitive and voltage-dependent, although it also affected the n(H) of the dose-response curve."( Diverse inhibitory actions of quaternary ammonium cholinesterase inhibitors on Torpedo nicotinic ACh receptors transplanted to Xenopus oocytes.
Ivorra, I; Morales, A; Olivera-Bravo, S, 2007
)
0.57
" In the presence of higher lidocaine doses, nicotinic receptors were blocked both at positive and negative potentials, acetylcholine dose-response curve shifted to the right and lidocaine pre-application, before its co-application with acetylcholine, enhanced the current inhibition, indicating all together that lidocaine also blocked resting receptors; besides, it increased the current decay rate."( Multiple inhibitory actions of lidocaine on Torpedo nicotinic acetylcholine receptors transplanted to Xenopus oocytes.
Alberola-Die, A; González-Ros, JM; Ivorra, I; Martinez-Pinna, J; Morales, A, 2011
)
0.63
" Dose-response analysis indicates that the less potent Ba(2+) has a lower affinity rather than a lower efficacy."( Dissecting a regulatory calcium-binding site of CLC-K kidney chloride channels.
Fenollar-Ferrer, C; Forrest, LR; Gradogna, A; Pusch, M, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2,867)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901096 (38.23)18.7374
1990's1056 (36.83)18.2507
2000's455 (15.87)29.6817
2010's223 (7.78)24.3611
2020's37 (1.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 93.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index93.07 (24.57)
Research Supply Index7.99 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index173.53 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (93.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews101 (3.43%)6.00%
Case Studies5 (0.17%)4.05%
Observational0 (0.00%)0.25%
Other2,835 (96.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]